Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 25566 | 278 | 20.6 | 39% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
| 466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
| 25566 | 1 | OXAPROZIN//4 5 DIARYLOXAZOLE//4 ACETAMIDOPHENYL 2 5 P TOLUYL 1 METHYLPYRROLEACETATE PHARMACOKINETICS | 278 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | OXAPROZIN | authKW | 527213 | 4% | 40% | 12 |
| 2 | 4 5 DIARYLOXAZOLE | authKW | 109839 | 0% | 100% | 1 |
| 3 | 4 ACETAMIDOPHENYL 2 5 P TOLUYL 1 METHYLPYRROLEACETATE PHARMACOKINETICS | authKW | 109839 | 0% | 100% | 1 |
| 4 | ACTIVE OSTEOARTHROSIS | authKW | 109839 | 0% | 100% | 1 |
| 5 | ADVERSE DRUG REACT SECT | address | 109839 | 0% | 100% | 1 |
| 6 | AU 8001 | authKW | 109839 | 0% | 100% | 1 |
| 7 | CARRAGEENIN ED50 | authKW | 109839 | 0% | 100% | 1 |
| 8 | CAS 2210 63 1 | authKW | 109839 | 0% | 100% | 1 |
| 9 | CAS 82239 77 8 | authKW | 109839 | 0% | 100% | 1 |
| 10 | CLINICAL THERAPEUTIC TRIAL | authKW | 109839 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1890 | 48% | 0% | 134 |
| 2 | Rheumatology | 1531 | 14% | 0% | 38 |
| 3 | Medicine, General & Internal | 640 | 23% | 0% | 64 |
| 4 | Medicine, Research & Experimental | 472 | 16% | 0% | 45 |
| 5 | Toxicology | 162 | 8% | 0% | 22 |
| 6 | Chemistry, Medicinal | 150 | 8% | 0% | 21 |
| 7 | Urology & Nephrology | 6 | 2% | 0% | 6 |
| 8 | Chemistry, Analytical | 4 | 3% | 0% | 9 |
| 9 | Chemistry, Multidisciplinary | 3 | 5% | 0% | 15 |
| 10 | Ergonomics | 2 | 0% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ADVERSE DRUG REACT SECT | 109839 | 0% | 100% | 1 |
| 2 | MED CLIN 1 PHAGOCYTE PHYSIOPATHOL INFLAMMAT | 109839 | 0% | 100% | 1 |
| 3 | SVEN OFTENDALSVN 6 | 109839 | 0% | 100% | 1 |
| 4 | CLIN FORENS TOXICOL SECT | 54919 | 0% | 50% | 1 |
| 5 | DRUG SAFETY EVALUAT BRANCH | 54919 | 0% | 50% | 1 |
| 6 | REHABIL MED CONROD | 54919 | 0% | 50% | 1 |
| 7 | ICTM ELECT | 27458 | 0% | 25% | 1 |
| 8 | ACSRC | 12203 | 0% | 11% | 1 |
| 9 | FOOD SECTOR | 10982 | 0% | 10% | 1 |
| 10 | ADVERSE DRUG REACT UNIT | 7321 | 0% | 7% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | SEMINARS IN ARTHRITIS AND RHEUMATISM | 20255 | 7% | 1% | 19 |
| 2 | INVESTIGACION MEDICA INTERNACIONAL | 19739 | 1% | 4% | 4 |
| 3 | PHARMATHERAPEUTICA | 8708 | 2% | 2% | 5 |
| 4 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 8271 | 7% | 0% | 19 |
| 5 | CURRENT MEDICAL RESEARCH AND OPINION | 7981 | 6% | 0% | 18 |
| 6 | RHEUMATOLOGY AND REHABILITATION | 7598 | 1% | 2% | 3 |
| 7 | TGO-TIJDSCHRIFT VOOR GENEESMIDDELENONDERZOEK-JOURNAL OF DRUG RESEARCH-JDR | 4575 | 0% | 4% | 1 |
| 8 | DRUGS | 4397 | 5% | 0% | 15 |
| 9 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 3012 | 4% | 0% | 11 |
| 10 | JOURNAL OF CLINICAL PHARMACOLOGY | 2900 | 4% | 0% | 12 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | OXAPROZIN | 527213 | 4% | 40% | 12 | Search OXAPROZIN | Search OXAPROZIN |
| 2 | 4 5 DIARYLOXAZOLE | 109839 | 0% | 100% | 1 | Search 4+5+DIARYLOXAZOLE | Search 4+5+DIARYLOXAZOLE |
| 3 | 4 ACETAMIDOPHENYL 2 5 P TOLUYL 1 METHYLPYRROLEACETATE PHARMACOKINETICS | 109839 | 0% | 100% | 1 | Search 4+ACETAMIDOPHENYL+2+5+P+TOLUYL+1+METHYLPYRROLEACETATE+PHARMACOKINETICS | Search 4+ACETAMIDOPHENYL+2+5+P+TOLUYL+1+METHYLPYRROLEACETATE+PHARMACOKINETICS |
| 4 | ACTIVE OSTEOARTHROSIS | 109839 | 0% | 100% | 1 | Search ACTIVE+OSTEOARTHROSIS | Search ACTIVE+OSTEOARTHROSIS |
| 5 | AU 8001 | 109839 | 0% | 100% | 1 | Search AU+8001 | Search AU+8001 |
| 6 | CARRAGEENIN ED50 | 109839 | 0% | 100% | 1 | Search CARRAGEENIN+ED50 | Search CARRAGEENIN+ED50 |
| 7 | CAS 2210 63 1 | 109839 | 0% | 100% | 1 | Search CAS+2210+63+1 | Search CAS+2210+63+1 |
| 8 | CAS 82239 77 8 | 109839 | 0% | 100% | 1 | Search CAS+82239+77+8 | Search CAS+82239+77+8 |
| 9 | CLINICAL THERAPEUTIC TRIAL | 109839 | 0% | 100% | 1 | Search CLINICAL+THERAPEUTIC+TRIAL | Search CLINICAL+THERAPEUTIC+TRIAL |
| 10 | ETOPHYLLINE | 109839 | 0% | 100% | 1 | Search ETOPHYLLINE | Search ETOPHYLLINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | DAVIES, NM , (1998) CLINICAL PHARMACOKINETICS OF OXAPROZIN.CLINICAL PHARMACOKINETICS. VOL. 35. ISSUE 6. P. 425-436 | 26 | 81% | 6 |
| 2 | TODD, PA , BROGDEN, RN , (1986) OXAPROZIN - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY.DRUGS. VOL. 32. ISSUE 4. P. 291-312 | 34 | 87% | 29 |
| 3 | PLOSKER, GL , WAGSTAFF, AJ , (1995) TIAPROFENIC ACID - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND USE IN THE MANAGEMENT OF RHEUMATIC DISEASES.DRUGS. VOL. 50. ISSUE 6. P. 1050-1075 | 35 | 42% | 5 |
| 4 | SORKIN, EM , BROGDEN, RN , (1985) TIAPROFENIC ACID - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN RHEUMATIC DISEASES AND PAIN STATES.DRUGS. VOL. 29. ISSUE 3. P. 208 -235 | 21 | 88% | 36 |
| 5 | ANDREASSEN, KH , ELDRUP, J , HANSEN, RI , OSTER, S , (1999) TIAPROFENIC ACID-INDUCED CYSTITIS - THREE CASES AND A LITERATURE REVIEW.SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. VOL. 33. ISSUE 6. P. 408-410 | 11 | 85% | 1 |
| 6 | DAVIES, NM , (1996) CLINICAL PHARMACOKINETICS OF TIAPROFENIC ACID AND ITS ENANTIOMERS.CLINICAL PHARMACOKINETICS. VOL. 31. ISSUE 5. P. 331-347 | 25 | 38% | 9 |
| 7 | GANESH, M , THANGABALAN, B , PATIL, R , GANGULY, S , SIVAKUMAR, T , (2008) SIMPLE EXTRACTIVE COLORIMETRIC DETERMINATION OF OXAPROZIN BY ACID-DYE COMPLEXATION METHODS IN SOLID DOSAGE FORM.E-JOURNAL OF CHEMISTRY. VOL. 5. ISSUE 3. P. 593-597 | 6 | 100% | 3 |
| 8 | DALLEGRI, F , BERTOLOTTO, M , OTTONELLO, L , (2005) A REVIEW OF THE EMERGING PROFILE OF THE ANTI-INFLAMMATORY DRUG OXAPROZIN.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 6. ISSUE 5. P. 777-785 | 14 | 45% | 5 |
| 9 | MARLAND, A , SARKAR, P , LEAVITT, R , LEE-RUFF, E , RAMNAUTH, J , (1999) THE ELIMINATION PROFILES OF OXAPROZIN IN EQUINE URINE AND SERUM AFTER A 4.8-G DOSE.JOURNAL OF ANALYTICAL TOXICOLOGY. VOL. 23. ISSUE 4. P. 242 -246 | 7 | 100% | 0 |
| 10 | BUCHBINDER, R , FORBES, A , KOBBEN, F , BOYD, I , SNOW, RM , MCNEIL, JJ , (2000) CLINICAL FEATURES OF TIAPROFENIC ACID (SURGAM) ASSOCIATED CYSTITIS AND A STUDY OF RISK FACTORS FOR ITS DEVELOPMENT.JOURNAL OF CLINICAL EPIDEMIOLOGY. VOL. 53. ISSUE 10. P. 1013-1019 | 8 | 73% | 4 |
Classes with closest relation at Level 1 |